Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model.

Hryckowian AJ, Van Treuren W, Smits SA, Davis NM, Gardner JO, Bouley DM, Sonnenburg JL.

Nat Microbiol. 2018 Jun;3(6):662-669. doi: 10.1038/s41564-018-0150-6. Epub 2018 Apr 23.

2.

A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites.

Dodd D, Spitzer MH, Van Treuren W, Merrill BD, Hryckowian AJ, Higginbottom SK, Le A, Cowan TM, Nolan GP, Fischbach MA, Sonnenburg JL.

Nature. 2017 Nov 30;551(7682):648-652. doi: 10.1038/nature24661. Epub 2017 Nov 22.

3.

The emerging metabolic view of Clostridium difficile pathogenesis.

Hryckowian AJ, Pruss KM, Sonnenburg JL.

Curr Opin Microbiol. 2017 Feb;35:42-47. doi: 10.1016/j.mib.2016.11.006. Epub 2016 Dec 19. Review.

4.

A small-molecule antivirulence agent for treating Clostridium difficile infection.

Bender KO, Garland M, Ferreyra JA, Hryckowian AJ, Child MA, Puri AW, Solow-Cordero DE, Higginbottom SK, Segal E, Banaei N, Shen A, Sonnenburg JL, Bogyo M.

Sci Transl Med. 2015 Sep 23;7(306):306ra148. doi: 10.1126/scitranslmed.aac9103. Epub 2015 Sep 23.

5.

dsdA Does Not Affect Colonization of the Murine Urinary Tract by Escherichia coli CFT073.

Hryckowian AJ, Baisa GA, Schwartz KJ, Welch RA.

PLoS One. 2015 Sep 14;10(9):e0138121. doi: 10.1371/journal.pone.0138121. eCollection 2015.

6.

Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance.

Ferreyra JA, Wu KJ, Hryckowian AJ, Bouley DM, Weimer BC, Sonnenburg JL.

Cell Host Microbe. 2014 Dec 10;16(6):770-7. doi: 10.1016/j.chom.2014.11.003.

7.

IraL is an RssB anti-adaptor that stabilizes RpoS during logarithmic phase growth in Escherichia coli and Shigella.

Hryckowian AJ, Battesti A, Lemke JJ, Meyer ZC, Welch RA.

MBio. 2014 May 27;5(3):e01043-14. doi: 10.1128/mBio.01043-14.

8.
9.

Isolation of generalized transducing bacteriophages for uropathogenic strains of Escherichia coli.

Battaglioli EJ, Baisa GA, Weeks AE, Schroll RA, Hryckowian AJ, Welch RA.

Appl Environ Microbiol. 2011 Sep;77(18):6630-5. doi: 10.1128/AEM.05307-11. Epub 2011 Jul 22.

10.

Comparative genomic analysis of 60 Mycobacteriophage genomes: genome clustering, gene acquisition, and gene size.

Hatfull GF, Jacobs-Sera D, Lawrence JG, Pope WH, Russell DA, Ko CC, Weber RJ, Patel MC, Germane KL, Edgar RH, Hoyte NN, Bowman CA, Tantoco AT, Paladin EC, Myers MS, Smith AL, Grace MS, Pham TT, O'Brien MB, Vogelsberger AM, Hryckowian AJ, Wynalek JL, Donis-Keller H, Bogel MW, Peebles CL, Cresawn SG, Hendrix RW.

J Mol Biol. 2010 Mar 19;397(1):119-43. doi: 10.1016/j.jmb.2010.01.011. Epub 2010 Jan 11.

11.

Exploring the mycobacteriophage metaproteome: phage genomics as an educational platform.

Hatfull GF, Pedulla ML, Jacobs-Sera D, Cichon PM, Foley A, Ford ME, Gonda RM, Houtz JM, Hryckowian AJ, Kelchner VA, Namburi S, Pajcini KV, Popovich MG, Schleicher DT, Simanek BZ, Smith AL, Zdanowicz GM, Kumar V, Peebles CL, Jacobs WR Jr, Lawrence JG, Hendrix RW.

PLoS Genet. 2006 Jun;2(6):e92. Epub 2006 Jun 9.

Supplemental Content

Loading ...
Support Center